Temsan-H Tablet is prescribed for the long-term management of hypertension following clinical confirmation of persistently elevated blood pressure and evaluation of overall cardiovascular risk. Dosing decisions are based on serial blood pressure trends, comorbid conditions such as diabetes or chronic kidney disease, renal function, electrolyte status, and individual treatment response. Any initiation, discontinuation, or modification of therapy should be undertaken only under medical supervision rather than in response to isolated home blood pressure readings.